Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
for
HIV, Immunodeficiencies, Infectious Diseases
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT00001281
Recruiting
Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
Location: New Hyde Park NY, Neptune City NJ, Hackensack NJ,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 1 - 17
Code: NCT05003986
Phase2, Recruiting
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
for
Autoimmune Lymphoproliferative Syndrome
Location: Philadelphia PA, Bethesda MD, Houston TX
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 16 - 70+
Code: NCT06730126
Phase2, Recruiting
Interested in new autoimmune diseases trials?
Get alerts for new trials in your area by subscribing now
Metformin for HIV Inflammation
for
HIV, Coronary Artery Disease
Location: Honolulu HI
Sponsor: University of Hawaii
Sex: All
Age: 45+
Code: NCT02383563
Phase2, Recruiting
Observational Pharmaco-Epidemiology Research & Analysis
for
Chronic Disease, HIV/AIDS, Liver Diseases,
Location: Durham NC
Sponsor: Epividian
Sex: All
Age: 0+
Code: NCT03813862
Recruiting
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
for
Thyroid Eye Disease, Graves Orbitopathy,
Location: Miami FL, Morgantown WV
Sponsor: Sling Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06112340
Phase2, Phase3, Recruiting
IS-free Treg HaploHCT
for
Stem Cell Transplant Complications, Graft Vs Host Disease,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18 - 70+
Code: NCT04678401
Phase1, Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Boston MA, Monroe NY, Pottstown PA, Newark DE,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT06727604
Phase2, Recruiting
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
for
Human Immunodeficiency Virus, Castleman's Disease,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03300830
Recruiting
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
for
Primary Immune Regulatory Disorder,
Location: New York NY, Philadelphia PA, Atlanta GA, Milwaukee WI,
Sponsor: Joseph Oved
Sex: All
Age: 0+
Code: NCT05787574
Phase2, Recruiting
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
for
HIV Infections, Sexually Transmitted Diseases
Location: Washington DC, Miami FL, San Francisco CA
Sponsor: Public Health Foundation Enterprises, Inc.
Sex: All
Age: 15+
Code: NCT04855773
Recruiting
Evaluation of Patients With Immune Function Abnormalities
for
Chronic Granulomatous Disease (CGD),
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 0+
Code: NCT00128973
Recruiting
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
for
Dyslipidemias, Cardiovascular Diseases, HIV Infections,
Location: Houston TX, Los Angeles CA, San Francisco CA
Sponsor: Priscilla Hsue, MD
Sex: All
Age: 40+
Code: NCT05488431
Phase2, Recruiting
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
for
Inflammatory Bowel Disease
Location: Charleston SC, Chicago IL
Sponsor: Rush University Medical Center
Sex: All
Age: 18+
Code: NCT05579392
Recruiting
Duloxetine in Inflammatory Bowel Diseases
for
Inflammatory Bowel Diseases
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 24+
Code: NCT07431606
Phase2, Recruiting
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV